Rolf Turk

2.5k total citations · 1 hit paper
25 papers, 1.4k citations indexed

About

Rolf Turk is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Rolf Turk has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 7 papers in Genetics and 4 papers in Oncology. Recurrent topics in Rolf Turk's work include CRISPR and Genetic Engineering (11 papers), Muscle Physiology and Disorders (9 papers) and Virus-based gene therapy research (5 papers). Rolf Turk is often cited by papers focused on CRISPR and Genetic Engineering (11 papers), Muscle Physiology and Disorders (9 papers) and Virus-based gene therapy research (5 papers). Rolf Turk collaborates with scholars based in United States, Netherlands and Japan. Rolf Turk's co-authors include Garrett R. Rettig, Mark A. Behlke, Peter A.C. ’t Hoen, Ashley M. Jacobi, Johan T. den Dunnen, Matthew McNeill, Michael A. Collingwood, Shuqi Yan, Ellen Sterrenburg and Kevin P. Campbell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Rolf Turk

25 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells

2018 541 citations Christopher A. Vakulskas, Daniel P. Dever et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rolf Turk United States	17	1.2k	317	132	119	87	25	1.4k
Ashley M. Jacobi United States	17	1.5k 1.3×	366 1.2×	163 1.2×	74 0.6×	81 0.9×	25	1.9k
H. Steve Zhang United States	4	1.7k 1.4×	542 1.7×	126 1.0×	73 0.6×	141 1.6×	6	1.9k
Russell C. DeKelver United States	15	2.0k 1.6×	673 2.1×	179 1.4×	200 1.7×	65 0.7×	29	2.2k
Jonathan D. Chesnut United States	22	2.1k 1.8×	492 1.6×	170 1.3×	48 0.4×	114 1.3×	38	2.4k
Richard L. Frock United States	18	2.1k 1.7×	313 1.0×	249 1.9×	68 0.6×	51 0.6×	29	2.3k
Jean-Baptiste Renaud France	6	1.4k 1.1×	339 1.1×	61 0.5×	66 0.6×	50 0.6×	7	1.6k
Joel R. Chamberlain United States	15	1.4k 1.1×	562 1.8×	94 0.7×	96 0.8×	81 0.9×	23	1.6k
Jennifer M. Cherone United States	5	1.3k 1.0×	276 0.9×	50 0.4×	83 0.7×	124 1.4×	8	1.4k
Noriko Sasakawa Japan	9	993 0.8×	229 0.7×	166 1.3×	70 0.6×	84 1.0×	10	1.2k
Sarah J. Hinkley United States	6	2.4k 2.0×	706 2.2×	134 1.0×	81 0.7×	103 1.2×	8	2.6k

Countries citing papers authored by Rolf Turk

Since Specialization

Citations

This map shows the geographic impact of Rolf Turk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Turk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Turk more than expected).

Fields of papers citing papers by Rolf Turk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf Turk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Turk. The network helps show where Rolf Turk may publish in the future.

Co-authorship network of co-authors of Rolf Turk

This figure shows the co-authorship network connecting the top 25 collaborators of Rolf Turk. A scholar is included among the top collaborators of Rolf Turk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf Turk. Rolf Turk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xiang, Jingyu, Jessica M. Devenport, Karl Staser, et al.. (2023). An “Off-the-Shelf” CD2 Universal CAR-T Therapy Combined with a Long-Acting IL-7 for T-Cell Malignancies. Blood. 142(Supplement 1). 764–764. 3 indexed citations

Xiang, Jingyu, Jessica M. Devenport, Karl Staser, et al.. (2023). An “off-the-shelf” CD2 universal CAR-T therapy for T-cell malignancies. Leukemia. 37(12). 2448–2456. 24 indexed citations

Kurgan, Gavin, Rolf Turk, Heng Li, et al.. (2021). CRISPAltRations: A validated cloud-based approach for interrogation of double-strand break repair mediated by CRISPR genome editing. Molecular Therapy — Methods & Clinical Development. 21. 478–491. 13 indexed citations

Turk, Rolf. (2021). CRISPR Applications in Medicine Depend on Minimizing Off-Target Editing. Genetic Engineering & Biotechnology News. 41(9). 64–66. 1 indexed citations

Quintana-Bustamante, Óscar, Daniel P. Dever, Rebeca Sánchez‐Domínguez, et al.. (2021). Clinically relevant gene editing in hematopoietic stem cells for the treatment of pyruvate kinase deficiency. Molecular Therapy — Methods & Clinical Development. 22. 237–248. 13 indexed citations

Schubert, Mollie S., Bernice Thommandru, Jessica Woodley, et al.. (2021). Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair. Scientific Reports. 11(1). 19482–19482. 64 indexed citations

Jacobi, Ashley M., Matthew McNeill, Rolf Turk, et al.. (2020). Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant System. Molecular Therapy — Methods & Clinical Development. 17. 1097–1107. 42 indexed citations

Vakulskas, Christopher A., Daniel P. Dever, Garrett R. Rettig, et al.. (2018). A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells. Nature Medicine. 24(8). 1216–1224. 541 indexed citations breakdown →

Jacobi, Ashley M., Garrett R. Rettig, Rolf Turk, et al.. (2017). Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes. Methods. 121-122. 16–28. 102 indexed citations

10.

Turk, Rolf, et al.. (2017). Dystroglycan Maintains Inner Limiting Membrane Integrity to Coordinate Retinal Development. Journal of Neuroscience. 37(35). 8559–8574. 27 indexed citations

11.

Rader, Erik P., Rolf Turk, Tobias Willer, et al.. (2016). Role of dystroglycan in limiting contraction-induced injury to the sarcomeric cytoskeleton of mature skeletal muscle. Proceedings of the National Academy of Sciences. 113(39). 10992–10997. 36 indexed citations

12.

Turk, Rolf, et al.. (2016). Molecular Signatures of Membrane Protein Complexes Underlying Muscular Dystrophy. Molecular & Cellular Proteomics. 15(6). 2169–2185. 18 indexed citations

13.

Satz, Jakob S., Adam P. Ostendorf, Shangwei Hou, et al.. (2010). Distinct Functions of Glial and Neuronal Dystroglycan in the Developing and Adult Mouse Brain. Journal of Neuroscience. 30(43). 14560–14572. 104 indexed citations

14.

Hoen, Peter A.C. ’t, Emile J. de Meijer, Judith M. Boer, et al.. (2007). Generation and Characterization of Transgenic Mice with the Full-length Human DMD Gene. Journal of Biological Chemistry. 283(9). 5899–5907. 64 indexed citations

15.

Vinciotti, Veronica, Xiaohui Liu, Rolf Turk, Emile J. de Meijer, & Peter A.C. ’t Hoen. (2006). Exploiting the full power of temporal gene expression profiling through a new statistical test: Application to the analysis of muscular dystrophy data. BMC Bioinformatics. 7(1). 183–183. 9 indexed citations

16.

Sterrenburg, Ellen, Stefan J. White, Rolf Turk, et al.. (2006). Gene expression profiling highlights defective myogenesis in DMD patients and a possible role for bone morphogenetic protein 4. Neurobiology of Disease. 23(1). 228–236. 22 indexed citations

17.

Hoen, Peter A.C. ’t, Annemieke Aartsma‐Rus, Rolf Turk, et al.. (2006). Gene Expression Profiling to Monitor Therapeutic and Adverse Effects of Antisense Therapies for Duchenne Muscular Dystrophy. Pharmacogenomics. 7(3). 281–297. 21 indexed citations

18.

Turk, Rolf, et al.. (2005). Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling. BMC Genomics. 6(1). 98–98. 87 indexed citations

19.

Turk, Rolf, Peter A.C. ’t Hoen, Ellen Sterrenburg, et al.. (2004). Gene expression variation between mouse inbred strains. BMC Genomics. 5(1). 57–57. 26 indexed citations

20.

Sterrenburg, Ellen, Rolf Turk, Peter A.C. ’t Hoen, et al.. (2004). Large-scale gene expression analysis of human skeletal myoblast differentiation. Neuromuscular Disorders. 14(8-9). 507–518. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact